SLC2A1 and neoplasm: Both in vitro and in vivo results demonstrate that the released Gen from (Gen + Cur)@FOS can specifically inhibit the expression of GLUT1 to block the glucose uptake pathway of tumor cells (i.e., “valve‐closing”), causing the starvation of tumor cells.